221 related articles for article (PubMed ID: 6252948)
1. The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentrations in postmenopausal women.
Paterson ME; Sturdee DW; Moore B; Whitehead TP
Br J Obstet Gynaecol; 1980 Jul; 87(7):552-60. PubMed ID: 6252948
[TBL] [Abstract][Full Text] [Related]
2. The effect of menopausal status and sequential mestranol and norethisterone on serum cholesterol, triglyceride and electrophoretic lipoprotein patterns.
Paterson ME; Sturdee DW; Moore B; Whitehead TP
Br J Obstet Gynaecol; 1979 Oct; 86(10):810-5. PubMed ID: 508663
[TBL] [Abstract][Full Text] [Related]
3. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
6. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
Furuhjelm M; Carlström K
Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
[TBL] [Abstract][Full Text] [Related]
7. Serum lipids during oestradiol-valerate/norgestrel treatment of menopausal women. Double-blind study of a sequential preparation.
Christensen NC; Davidsen PC; Secher NJ; Pedersen GT
Acta Obstet Gynecol Scand; 1975; 54(3):213-6. PubMed ID: 1099859
[TBL] [Abstract][Full Text] [Related]
8. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
10. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
11. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
Hirvonen E; Mälkönen M; Manninen V
N Engl J Med; 1981 Mar; 304(10):560-3. PubMed ID: 7453723
[TBL] [Abstract][Full Text] [Related]
12. The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subfractions in postmenopausal women.
Farish E; Fletcher CD; Hart DM; Teo HT; Alazzawi F; Howie C
Acta Endocrinol (Copenh); 1986 Sep; 113(1):123-7. PubMed ID: 3020851
[TBL] [Abstract][Full Text] [Related]
13. Effect of oestrogen and progesterone on fasting serum cholesterol and triglyceride levels in post-menopausal women.
Varma TR; Morsman J
Int J Gynaecol Obstet; 1982 Apr; 20(2):91-7. PubMed ID: 6125443
[No Abstract] [Full Text] [Related]
14. Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women.
Varma TR
Int J Gynaecol Obstet; 1983 Aug; 21(4):291-6. PubMed ID: 6141083
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral contraceptives on lipoprotein triglyceride and cholesterol: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):725-31. PubMed ID: 7065054
[TBL] [Abstract][Full Text] [Related]
16. Long-term post-menopausal hormone therapy and serum HDL-C, total cholesterol and triglycerides.
Vilska S; Punnonen R; Rauramo L
Maturitas; 1983 Aug; 5(2):97-104. PubMed ID: 6415365
[TBL] [Abstract][Full Text] [Related]
17. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
18. The influence of oral contraceptive steroids on serum lipids.
De Alvarez RR; Jahed FM; Spitalny KJ; Elkin H; Jaunakais I
Am J Obstet Gynecol; 1973 Jul; 116(5):727-49. PubMed ID: 4351501
[TBL] [Abstract][Full Text] [Related]
19. Menopausal therapy and endometrial pathology.
Craft I; Swinhoe J; Mugglestone CJ
Br Med J; 1978 Aug; 2(6134):429-30. PubMed ID: 687955
[TBL] [Abstract][Full Text] [Related]
20. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
